Electra Therapeutics, Inc.

📈 Chart on TradingView 💰 Financials on Finviz

$ETRA

$7.35

Current Price

N/A

Market Cap

52W Low$6.87

Current$7.355.6% above low, 94.4% below high

52W High$15.50

Insider Activity Statistics

Aggregated buying and selling activity by time period

Period	Type	Insiders	Transactions	Value	Shares	Buy/Sell Ratio
1 week	Buys	2	20	$7,210,232.78	945,142	All Buys
1 week	Sells	0	0	-	-	All Buys
2 weeks	Buys	2	20	$7,210,232.78	945,142	All Buys
2 weeks	Sells	0	0	-	-	All Buys
1 month	Buys	2	20	$7,210,232.78	945,142	All Buys
1 month	Sells	0	0	-	-	All Buys
2 months	Buys	2	24	$47,210,222.78	3,611,808	All Buys
2 months	Sells	0	0	-	-	All Buys
3 months	Buys	2	24	$47,210,222.78	3,611,808	All Buys
3 months	Sells	0	0	-	-	All Buys
See activity going back 12 months — create a free account

Insider Transactions

Recent purchases and sales by company insiders

Date	Insider	Type	Shares	Price	Value	Actions
Nov 3, 2026	GORDON CARL L Director	Purchase	97,800	$7.84	$766,752.00	View Details
Nov 4, 2026	GORDON CARL L Director	Purchase	37,100	$7.78	$288,638.00	View Details
Nov 3, 2026	GORDON CARL L Director	Purchase	24,313	$7.84	$190,613.92	View Details
Nov 4, 2026	GORDON CARL L Director	Purchase	9,267	$7.78	$72,097.26	View Details
Nov 4, 2026	GORDON CARL L Director	Purchase	5,000	$7.07	$35,350.00	View Details
Nov 4, 2026	GORDON CARL L Director	Purchase	20,000	$7.07	$141,400.00	View Details
Nov 5, 2026	GORDON CARL L Director	Purchase	125,200	$7.31	$915,212.00	View Details
Nov 3, 2026	GORDON CARL L Director	Purchase	24,400	$7.88	$192,272.00	View Details
Nov 3, 2026	GORDON CARL L Director	Purchase	98,600	$7.88	$776,968.00	View Details
Nov 5, 2026	GORDON CARL L Director	Purchase	30,891	$7.31	$225,813.21	View Details
Nov 3, 2026	ORBIMED ADVISORS LLC Director	Purchase	98,600	$7.88	$776,968.00	View Details
Nov 4, 2026	ORBIMED ADVISORS LLC Director	Purchase	9,267	$7.78	$72,097.26	View Details
Nov 5, 2026	ORBIMED ADVISORS LLC Director	Purchase	125,200	$7.31	$915,212.00	View Details
Nov 3, 2026	ORBIMED ADVISORS LLC Director	Purchase	24,400	$7.88	$192,272.00	View Details
Nov 4, 2026	ORBIMED ADVISORS LLC Director	Purchase	5,000	$7.07	$35,350.00	View Details
Nov 4, 2026	ORBIMED ADVISORS LLC Director	Purchase	20,000	$7.07	$141,400.00	View Details
Nov 5, 2026	ORBIMED ADVISORS LLC Director	Purchase	30,891	$7.31	$225,813.21	View Details
Nov 3, 2026	ORBIMED ADVISORS LLC Director	Purchase	24,313	$7.84	$190,613.92	View Details
Nov 4, 2026	ORBIMED ADVISORS LLC Director	Purchase	37,100	$7.78	$288,638.00	View Details
Nov 3, 2026	ORBIMED ADVISORS LLC Director	Purchase	97,800	$7.84	$766,752.00	View Details

Showing 1–20 of 24 transactions

Upcoming Earnings

Scheduled earnings reports

No upcoming earnings scheduled

Past Earnings

Historical earnings results

No past earnings data available

Related Activity

Cross-company insider connections and cluster buy signals

Cluster Buy Signals

$ETRA appeared in 2 cluster buy signals:

Nov 3, 20262 insiders · $7,210,232.78 Sep 21, 20262 insiders · $39,999,990.00

Insiders Also Active At

Insiders at this company also hold positions or have traded at these companies:

$TRAW — Traws Pharma, Inc.via ORBIMED ADVISORS LLC $QTTB — Q32 Bio Inc.via ORBIMED ADVISORS LLC $PRLD — Prelude Therapeutics Incvia ORBIMED ADVISORS LLC $STTK — Shattuck Labs, Inc.via ORBIMED ADVISORS LLC $EWTX — Edgewise Therapeutics, Inc.via ORBIMED ADVISORS LLC $ACET — Adicet Bio, Inc.via ORBIMED ADVISORS LLC $MBX — MBX Biosciences, Inc.via ORBIMED ADVISORS LLC $ADRX — ADARx Pharmaceuticals, Inc.via GORDON CARL L $BLSM — BlossomHill Therapeutics, Inc.via GORDON CARL L $SCTX — Scribe Therapeutics, Inc.via GORDON CARL L

Average Insider